Speaker Details

Tom Hillary, MD

Tom Hillary, MD

SESSIONS

U081 Malignancy Risk and Immunomodulatory Therapy
Mar 22, 2027 • 7:30 AM - 8:30 AM

DISCLOSURES

No financial relationships exist with ineligible companies.